Trial intelligence / Profile preview

HPMC-Zein Based 5-fluorouracil Gel for Stable Vitiligo

NCT06209138Completed

Sponsor
Al-Azhar University
Start
Jan 2024
Primary completion
Apr 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of fluorouracil in Vitiligo (2 arms), sponsored by Al-Azhar University. Primary endpoints: Quartile grading scale at 2 months and JAK3 expression in vitiligo lesions at 2 months. Started Jan 2024; status: completed.

02

Drugs

fluorouracil
03

Conditions

Vitiligo

Beyond the preview

Go deeper on NCT06209138.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06209138.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call